$1.30
▲ +$0.08
(+6.56%)
Vol 4.1M
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.6M
ROE
-45.0%
Margin
-22.9%
D/E
46.94
Beta
-0.26
52W
$0–$5
Price Chart
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -45.0% | — | — | — | — | -45.0% |
| P/E (TTM) | — | 4.44 | 2.21 | 2.00 | 1.41 | — |
| Net Margin | -96.9% | 12.4% | 12.4% | 12.4% | 12.4% | -22.9% |
| Gross Margin | 31.3% | 30.3% | 30.3% | 30.3% | 30.3% | 30.9% |
| D/E Ratio | 46.94 | 39.90 | 39.90 | 39.90 | 39.90 | 46.94 |
| Current Ratio | 1.75 | 1.62 | 1.62 | 1.62 | 1.62 | 1.75 |
Key Ratios
ROA (TTM)
-21.2%
P/S (TTM)
0.06
P/B
1.6
EPS (TTM)
$-0.47
Rev Growth 3Y
+45.3%
52W High
$4.53
52W Low
$0.30
$0.30
52-Week Range
$4.53
How does STAK compare to Energy peers?
Peer group: Micro-cap Energy (All) · 70 companies
STAK valuation vs Energy peers
P/E ratio
—
▼
0%
below
peers
(14.7)
vs Peers
vs Industry
Fair value
P/S ratio
0.1
▼
94%
below
peers
(1.2)
vs Peers
vs Industry
Undervalued
P/B ratio
1.6
▲
0%
above
peers
(1.6)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(3.7%)
vs Peers
vs Industry
Low yield
STAK profitability vs Energy peers
ROE
-45.0%
▼
2930%
below
peers
(1.6%)
vs Peers
vs Industry
Weak
Net margin
-22.9%
▼
5832%
below
peers
(0.4%)
vs Peers
vs Industry
Weak
Gross margin
30.9%
▼
1%
below
peers
(31.2%)
vs Peers
vs Industry
In line
ROA
-21.2%
▼
30171%
below
peers
(-0.1%)
vs Peers
vs Industry
Weak
STAK financial health vs Energy peers
D/E ratio
46.9
▲
23%
above
peers
(38.2)
vs Peers
vs Industry
Above avg
Current ratio
1.8
▲
10%
above
peers
(1.6)
vs Peers
vs Industry
In line
Beta
-0.3
▼
140%
below
peers
(0.7)
vs Peers
vs Industry
More volatile
STAK fundamentals radar
STAK
Peer median
Industry
STAK profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
STAK vs peers: key metrics
Latest News
Carlyle Group (CG) to Acquire Majority Stake in MAI Capital at $2.8B …
Yahoo Finance · Apr 06
SEC Case Against Musk Over Twitter Stake Heads to Trial
ZeroHedge · Apr 06
Analysis: Target repeats Starbucks’ big mistake
Yahoo Finance · Apr 05
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You …
Nasdaq · Apr 05
Why Buying VOO Might Actually Be a Mistake Right Now
Nasdaq · Apr 04